CONTACT US
Home > Reference Standards>Fungal> > iKIX1
iKIX1

iKIX1

  • CAT Number: R066661
  • CAS Number: 656222-54-7
  • Molecular Formula: C10H8Cl2N4OS
  • Molecular Weight: 303.2
  • Purity: ≥95%
Inquiry Now

iKIX1 (CAT: R066661) is an inhibitor targeting interactions between the transcription co-activator Mediator complex and the pleiotropic drug resistance (CgPdr1) transcription factor in Candida glabrata. It functions by blocking the interaction between the KIX domain of the Mediator subunit CgGal11A and the activation domain of CgPdr1, with an IC50 of 190.2 μM. Pharmacologically, iKIX1 (10 and 30 μM) effectively inhibits ketoconazole-induced expression of CgPdr1-target genes responsible for multidrug resistance and drug efflux in C. glabrata. This potential therapeutic agent shows promise in combating drug resistance in C. glabrata infections, warranting further exploration in antimicrobial strategies.

Catalog Number R066661
CAS Number 656222-54-7
Synonyms

2-cyano-acetic acid, 2-[[(3,4-dichlorophenyl)amino]thioxomethyl]hydrazide

Molecular Formula

C10H8Cl2N4OS

Purity 95%
Storage -20°C
InChI InChI=1S/C10H8Cl2N4OS/c11-7-2-1-6(5-8(7)12)14-10(18)16-15-9(17)3-4-13/h1-2,5H,3H2,(H,15,17)(H2,14,16,18)
InChIKey XKQJVBSDCOCZFV-UHFFFAOYSA-N
SMILES ClC1=C(Cl)C=CC(NC(NNC(CC#N)=O)=S)=C1

Request a Quote

Contact Us at MuseChem

We are committed to providing you with reliable, cost-effective solutions for your chemical needs, while ensuring your safety and comfort. Our team of experts is always available to answer your questions and help you navigate the complexities of the chemical industry.

Whether you're looking for a specific product or need help with a custom synthesis project, we're here to help you discover a new world of chemical possibilities. Contact us today to learn more about how we can assist you with all of your chemical needs.

Our goal is to make the process of ordering chemicals as seamless and hassle-free as possible. Let us know how we can assist you, and we'll get back to you as soon as possible. We look forward to hearing from you!